SimBioSys news
The latest SimBioSys news, : FDA clears SimBioSys’s TumorSight Risk for breast cancer recurrence risk.
2 stories mentioning SimBioSys since 5 October 2026, newest first, each with its sources and discussion. Follow to see new ones on your front page.
-
FDA clears SimBioSys’s TumorSight Risk for breast cancer recurrence risk
The tool covers 75 percent of U.S. breast cancer cases, according to the company, and uses proprietary spatial AI modeling on existing MRI data without additional procedures or hardware. The clearance follows a…
1 sourceUnite.AI -
NVIDIA Inception startups use AI to improve breast cancer screening and care
NVIDIA highlights four startups in its Inception program that are deploying AI to address critical gaps in breast cancer care, ranging from screening to treatment planning. The initiative responds to a projected…
1 source primary sourceNVIDIA Blog
Questions about SimBioSys
What is the latest SimBioSys news?
As of 15 October 2026: FDA clears SimBioSys’s TumorSight Risk for breast cancer recurrence risk. The tool covers 75 percent of U.S.